0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters |

Screening and Detection of Breast Cancer and Prostate Cancer

Emmanuel Saloustros, MD; Dimitris Mavroudis, MD
JAMA. 2010;303(11):1032-1034. doi:10.1001/jama.2010.273.
Text Size: A A A
Published online

Extract

To the Editor: The Special Communication by Dr Esserman and colleagues1 summarized several observations after 20 years of extensive screening for breast and prostate cancer (1986-2006). The authors referred to data from the Surveillance, Epidemiology and End Results (SEER) program to report that the incidence of total invasive breast cancer (excluding in situ lesions) has increased substantially and remains higher than prescreening rates, while the localized (node negative, no skin or chest wall involvement) and regional (node positive, skin or chest wall involvement) breast cancer incidence has declined only slightly. The authors concluded that the increase in the relative fraction of early stage cancers without decrease in the incidence of regional cancers is the result of preferential detection of the slower growing and potentially indolent tumors (length bias).

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

March 17, 2010
Nigel Paneth, MD, MPH; George Vande Woude, PhD; Eric Kort, MD, MSc
JAMA. 2010;303(11):1032-1034. doi:10.1001/jama.2010.274.
March 17, 2010
Marc B. Garnick, MD
JAMA. 2010;303(11):1032-1034. doi:10.1001/jama.2010.275.
March 17, 2010
Laura Esserman, MD, MBA; Ian Thompson, MD
JAMA. 2010;303(11):1032-1034. doi:10.1001/jama.2010.276.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();